Lineage Cell Therapeutics Inc (STU:BT3)
€ 0.915 -0.02 (-2.14%) Market Cap: 183.37 Mil Enterprise Value: 146.04 Mil PE Ratio: 0 PB Ratio: 2.73 GF Score: 77/100

Lineage Cell Therapeutics Inc (STU:BT3) Transcripts

  • 1